Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
97 participants
INTERVENTIONAL
2022-12-19
2023-08-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TNF-α Treatment of Blast-Induced Tinnitus
NCT04066348
Safety and Efficacy of Acupressure Applied Through ForgTin© in Patients With Tinnitus
NCT04623957
Short-term Oral Prednisone for Acute Subjective Tinnitus
NCT05591144
AM-101 in the Treatment of Acute Tinnitus 3
NCT02040194
Nitrous Oxide Treatment for Tinnitus
NCT03365011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MHNA-003
MHNA-003 is a self-guided digital program for people living with tinnitus
MHNA-003
MHNA-003 is a self-guided digital program for people living with tinnitus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MHNA-003
MHNA-003 is a self-guided digital program for people living with tinnitus
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant has experienced symptoms of tinnitus for at least 3 months.
* Participant is at least 18 years of age at the time of consent.
* Participant resides in the United States.
* Participant is able to speak, read, and understand English.
* Participant has access to an iOS or Android smartphone with the ability to complete study tasks.
* Participant is able to commit the time required to complete therapy modules and study assessments.
Exclusion Criteria
* Participant has been hospitalized for psychiatric reasons within 12 months of screening.
* Participant is currently enrolled in or plans to enroll in another clinical study that could impact outcomes of this trial.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahana Therapeutics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mahana Therapeutics
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MHNA-003-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.